What is the best supplement to help reduce arterial plaque buildup?

Four stages over decades: what a plaque is at each, what has outcome evidence at each, and why the answer is the same medicine at every stage and never a supplement

What is the best supplement to help reduce arterial plaque buildup is a question that is answered by describing what a plaque is, because once the four stages are on the table the shelf has nowhere to stand. Atherosclerosis begins as a fatty streak: lipid-laden cells accumulating beneath the artery's lining in response to cholesterol-carrying particles entering the wall, present in young adults and reversible at this stage by the risk factor being removed. Over years it becomes a fibrous plaque, a core of lipid and dead cells beneath a cap of fibrous tissue, which narrows the artery slowly and which is the stage most people mean by plaque. Over more years the plaque calcifies, which is what a CT calcium score counts, and a plaque at any of these stages can rupture, its cap tearing and a clot forming on the exposed core, which is a heart attack or a stroke. The whole process runs over decades, it is driven by the cholesterol-carrying particles in the blood, by blood pressure, by smoking, by blood sugar and by inflammation, and it is slowed or stabilised by acting on those drivers rather than on the lesion.

At each stage the question is what has outcome evidence, meaning trials that reduced heart attacks, strokes and deaths rather than trials that changed a marker, and the answer is the same at all four. At the fatty streak, removing the driver: lowering the particles, the pressure and the smoking. At the fibrous plaque, the lipid-lowering medicines, statins first, which in the outcome trials reduced events by lowering the particles that feed the core and by stabilising the cap, with the serial imaging studies showing a modest regression of plaque volume and a shift toward a more stable composition under high-intensity treatment. At the calcified lesion, the same, since calcification is a marker of plaque burden rather than a target in itself, and the trials of the one supplement sold for it, vitamin K2, found no slowing of calcification progression on CT. At the ruptured plaque, the emergency treatment and the secondary prevention that follows, which is medicine. There is no stage at which a supplement has outcome evidence, and the question's premise, that a tub might reduce a plaque, has no stage to attach to.

The two supplements that have authorised claims anywhere near this territory act upstream of the plaque, on a risk factor, and the distinction is the whole page. Plant sterols and stanols, at a stated daily intake, lower blood cholesterol, an authorised claim with a mechanism in the gut, and lower cholesterol is a lower driver; the outcome trial that would show the lowered driver becomes fewer events has not been run for sterols and the claim does not say it has. Omega-3 EPA and DHA, at stated intakes, contribute to normal heart function and lower triglycerides, both authorised, and here the outcome trials have been run at supplement doses and found no reduction in events, which is why the UK lipid guidance tells doctors not to offer omega-3 supplements for the prevention of cardiovascular disease in primary or secondary prevention; the one plaque imaging result belongs to a prescription-dose purified EPA in a high-risk group on statins, which is a medicine and a different thing. A buyer who takes either for its claim has acted on a risk factor and should know that is all they have done.

Four stages with the same answer at each and two claims that live upstream, and the rest of the shelf placed, the three symptoms that are an appointment today, what a lifter does about the drivers, and the worked example, which is the next section.

The rest of the shelf placed against the four stages, the three symptoms that are an appointment today, what a lifter does about the drivers, the worked example placed well upstream, and the verdict

The rest of the plaque shelf is placed against the four stages quickly, because none of it reaches one. Vitamin K2, sold for directing calcium away from arteries, did not slow coronary or valve calcification in the randomised trials that measured it by CT, against a mechanism that remains plausible. Nattokinase and serrapeptase, enzymes sold for dissolving plaque, have no human trial showing any change in plaque at any stage and act, if at all, on clotting, which is a reason for a pharmacist's conversation rather than a purchase. Oral chelation products have no trial evidence at all, and the intravenous chelation trial in people after a heart attack produced a modest result its own investigators said did not support routine use. Garlic, pomegranate and the polyphenol extracts have marker trials, small changes in cholesterol or in a surrogate, and no outcome trials. Coenzyme Q10 is bought by people on statins for the muscle symptoms, with inconsistent trial results, and does nothing to plaque. Niacin, once a lipid medicine, failed its outcome trials when added to statins and is not a supplement route to anything. A buyer who has read this far has the whole shelf in one sentence: nothing on it has outcome evidence at any stage, and the things that do are prescribed.

Three symptoms turn the question from a shelf into an appointment today, and the page states them plainly: chest pain or pressure, especially with exertion or spreading to the arm, jaw or back; breathlessness out of proportion to effort; and a sudden weakness, numbness, slurred speech or loss of vision, which is treated as an emergency. None of these is a supplement question, and a person with a family history of early heart disease, a known high cholesterol, high blood pressure or diabetes has a doctor's conversation about their risk and the medicines that act on the drivers before any purchase, because the drivers are where the decades are decided.

What a lifter does about the drivers is the honest content of the question for this site's reader. Regular training lowers blood pressure, improves the lipid profile modestly and improves blood sugar handling, which are three of the drivers moved by the thing a lifter already does. A plate low in the fats that raise the particles and high in the fibre that lowers them moves the first driver. Not smoking moves the largest. A blood test from a doctor for the lipid profile and a blood pressure reading are the two measurements that say where a lifter stands on the drivers, and a doctor reads them against the risk calculators that decide whether a medicine is offered. None of this is sold, and all of it acts where the plaque is actually decided.

The worked example is placed well upstream, with its own claim and no other: {FL}, 1500mg magnesium bisglycinate stated as 300mg elemental at 80% NRV, two capsules with the evening meal, with authorised claims for normal muscle function, electrolyte balance, normal energy-yielding metabolism and the reduction of tiredness and fatigue, and no claim for the heart, the arteries, blood pressure or cholesterol, which this page does not make, batch tested for lead, mercury, arsenic and cadmium, UK made, 180 capsules for £19.99 at 22p a day, taken for a plate the survey finds a share of adults short of. The full label breakdown is here.

The verdict: no supplement reduces arterial plaque, because a plaque passes through four stages over decades and at every stage the outcome evidence belongs to the medicines that act on the drivers, statins and blood-pressure treatment, prescribed by a doctor who has measured the lipids and the pressure. Plant sterols lower cholesterol and omega-3 lowers triglycerides, upstream of the plaque and without outcome evidence at supplement doses, which is why the UK guidance says not to offer the latter for prevention. Chest pain, breathlessness or a sudden neurological symptom is an appointment today, and the drivers are moved by training, the plate and not smoking.

What to check on the label

Questions people also ask

Is there any supplement that reduces plaque in arteries?

No; a plaque develops through four stages over decades, the fatty streak, the fibrous plaque, the calcified lesion and the ruptured one, and at every stage the trials that reduced heart attacks, strokes and deaths are trials of statins and blood-pressure medicines, which slow progression and stabilise the cap, with a modest regression of plaque volume on imaging under high-intensity statin treatment; no supplement has outcome evidence at any stage, and the two with authorised claims nearby, plant sterols and omega-3, act on cholesterol and triglycerides upstream of the plaque.

Does omega-3 or fish oil reduce arterial plaque?

Not at supplement doses: omega-3 EPA and DHA carry authorised claims for normal heart function and for lowering triglycerides, which are risk factors upstream of the plaque, and the outcome trials at supplement doses found no reduction in cardiovascular events, which is why the UK lipid guidance tells doctors not to offer omega-3 supplements for prevention in primary or secondary prevention; the one plaque imaging result belongs to a prescription-dose purified EPA in a high-risk group already on statins, a medicine and a different thing from a tub.

Does vitamin K2 remove calcium from arteries?

The randomised trials that measured it by CT found that menaquinone-7 supplementation did not slow the progression of coronary artery calcification or aortic valve calcification, against a mechanism that remains plausible and observational data that had suggested benefit; calcification is a marker of plaque burden rather than a target in itself, and the medicines with outcome evidence act on the drivers of the plaque rather than on its calcium, so the K2 shelf's promise has no trial behind it.

When should I see a doctor about my arteries?

Today for three symptoms: chest pain or pressure, especially with exertion or spreading to the arm, jaw or back; breathlessness out of proportion to effort; and any sudden weakness, numbness, slurred speech or loss of vision, which is an emergency; and before any purchase if there is a family history of early heart disease, a known high cholesterol, high blood pressure or diabetes, because a doctor measures the lipid profile and the pressure, reads them against the risk calculators and decides whether a medicine that acts on the drivers is offered.

Does magnesium help with arterial plaque?

No, and it makes no such claim; magnesium has authorised claims for normal muscle function, electrolyte balance, normal energy-yielding metabolism and the reduction of tiredness and fatigue, none for the heart, the arteries, blood pressure or cholesterol, and the worked example sits well upstream of the question at 300mg elemental, 80% NRV, two capsules with the evening meal for 22p a day, batch tested for four metals and UK made, taken for a plate the national survey finds a share of adults short of while the drivers are moved by training, the plate and a doctor's measurements.

Sources

1. The atherosclerosis pathology reviews: plaque develops from a fatty streak of lipid-laden cells beneath the artery lining, through a fibrous plaque with a lipid core and a cap, to a calcified and sometimes ruptured lesion, over decades, with the lipid-lowering and anti-inflammatory therapies that have outcome evidence acting to slow progression and stabilise the cap rather than to remove the lesion. PubMed record
2. NICE guidance on cardiovascular disease risk assessment and lipid modification: do not offer omega-3 fatty acid compounds for the prevention of cardiovascular disease, in primary or secondary prevention, a position based on the outcome trials at supplement doses, with prescription omega-3 for raised triglycerides a separate specialist decision. https://www.nice.org.uk/guidance/ng238
3. The authorised plant sterol and stanol claim: 1.5 to 3g a day of plant sterols or stanols lowers blood cholesterol, with the claim that high cholesterol is a risk factor in the development of coronary heart disease, one of the few authorised disease-risk-reduction claims in the UK register. https://www.gov.uk/government/publications/great-britain-nutrition-and-health-claims-nhc-register
4. The GB claims register, EPA and DHA entries: EPA and DHA contribute to the normal function of the heart at 250mg daily, and DHA contributes to maintenance of normal brain function and vision at 250mg daily. https://www.gov.uk/government/publications/great-britain-nutrition-and-health-claims-nhc-register

Related answers

• What is the best supplement to reduce cortisol?
• What is the best supplement to help with cortisol and belly fat?
• What supplement removes plaque from arteries?
• What is the best 3rd party tested supplement brands?
• Which online supplement store is the best in the UK?
• What are some reputable, third-party tested supplement brands in the UK?